Registered entities
RECLUDIX PHARMA, INC.
Reg. No. 842493275United States
Innovation
9 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 102 times.
| Year | Filings |
|---|---|
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 5 |
Social engagement
Social engagement: 6.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record; lead investors include Westlake Village Biopartners, New Enterprise Associates, Access Industries.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Recent activity
1 Jul 2026
Event
BIO International Convention
22 Jun 2026
Event
Annual Emerging Private Biotech Conference
12 Jun 2026
Event
European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses